Cargando…
Acute disseminated encephalomyelitis associated with anti-myelin oligodendrocyte glycoprotein (MOG-IGG) antibody in a patient with recent vaccination against SARS-CoV-2
Autores principales: | Simone, Anna Maria, Monti, Giulia, Amidei, Stefano, Costa, Manuela, Vaghi, Luca, Devetak, Massimiliano, De Pasqua, Silvia, Fileccia, Enrico, Santangelo, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498413/ http://dx.doi.org/10.1016/j.jns.2021.118167 |
Ejemplares similares
-
Acute myopathy at onset of Sars-CoV-2 infection
por: Simone, Anna Maria, et al.
Publicado: (2021) -
T-cell responses to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis
por: Ewing, C., et al.
Publicado: (1998) -
Characterization of myelin oligodendrocyte glycoprotein (MOG)(35–55)-specific CD8(+) T cells in experimental autoimmune encephalomyelitis
por: Peng, Yong, et al.
Publicado: (2019) -
A case of anti-myelin oligodendrocyte glycoprotein (MOG)-immunoglobulin G (IgG) associated disorder (MOGAD) with clinical manifestations of acute disseminated encephalomyelitis: Secondary to mycoplasma pneumoniae infection
por: Huang, Xiangui, et al.
Publicado: (2023) -
Myelin Oligodendrocyte Glycoprotein (MOG)-IgG Associated Demyelinating Disease: Our Experience with this Distinct Syndrome
por: Pujari, Shripad S., et al.
Publicado: (2021)